IFN-α IL-6和IL-17检测对结核病辅助诊断价值

被引:1
|
作者
刘战地
孙明玥
田二朋
马伟立
邸红芹
机构
[1] 河北省胸科医院
关键词
结核病; 细胞因子; IFN-α; IL-6; IL-17;
D O I
暂无
中图分类号
学科分类号
摘要
目的:评价血清免疫细胞因子对结核分枝杆菌肺病(TB)的诊断价值。方法:回顾性选取2020年11月至2022年10月于河北省胸科医院就诊的139例疑似肺结核患者作为研究对象。按照2018年最新实施的肺结核诊断标准(WS288-2017),其中确诊结核病69例,纳入结核组,非结核病70例纳入非结核组。采用流式免疫荧光发光法检测血清中免疫相关细胞因子IL-6、IL-17和IFN-α水平,并分析三种因子检测对结核病的诊断效能。结果:结核组患者IL-6浓度和IL-17浓度显著高于非结核组,差异有统计学意义(P<0.05);结核组患者IFN-α浓度略高于非结核组,但差异无统计学意义(P>0.05);进行ROC曲线分析:IL-6检测AUC面积为0.658(P<0.001)、IL-17检测AUC面积为0.734(P<0.001)、IFN-α检测AUC面积为0.571(P<0.001)。结论:MTB感染者IL-6、IL-17水平增高,IL-6、IL-17对结核的诊断具有较好的灵敏度和特异度;IL-6、IL-17在临床辅助诊断结核病具有一定的价值。
引用
收藏
页码:942 / 945
页数:4
相关论文
共 13 条
  • [1] 结核分枝杆菌致肺损伤的研究进展.[J].陆霓虹;李杰;.中国医药科学.2022, 16
  • [2] 干扰素α对小鼠Tfh细胞分化的调控作用
    兰亚如
    孙鹏
    段相国
    沈春秀
    张晓羽
    王琦
    苏春霞
    [J]. 动物医学进展, 2020, 41 (02) : 18 - 22
  • [3] Oxidative Stress and Inflammatory Mediators in Exhaled Breath Condensate of Patients with Pulmonary Tuberculosis. A Pilot Study with a Biomarker Perspective
    Guzman-Beltran, Silvia
    Carreto-Binaghi, Laura Elena
    Carranza, Claudia
    Torres, Martha
    Gonzalez, Yolanda
    Munoz-Torrico, Marcela
    Juarez, Esmeralda
    [J]. ANTIOXIDANTS, 2021, 10 (10)
  • [4] Risk of tuberculosis reactivation with IL-17 and IL-23 inhibitors in psoriasis - time for a paradigm change..[J].Nogueira Miguel;Warren Richard;Torres Tiago.Journal of the European Academy of Dermatology and Venereology : JEADV.2020, 4
  • [5] Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis
    Zhou, Guozhong
    Luo, Qingyi
    Luo, Shiqi
    Teng, Zhaowei
    Ji, Zhenhua
    Yang, Jiaru
    Wang, Feng
    Wen, Shiyuan
    Ding, Zhe
    Li, Lianbao
    Chen, Taigui
    Abi, Manzama-Esso
    Jian, Miaomiao
    Luo, Lisha
    Liu, Aihua
    Bao, Fukai
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (12): : 1457 - 1469
  • [6] The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB)
    Zellweger, Jean-Pierre
    Sotgiu, Giovanni
    Corradi, Massimo
    Durando, Paolo
    [J]. MEDICINA DEL LAVORO, 2020, 111 (03): : 170 - 183
  • [7] The pathogenicity of Th17 cells in autoimmune diseases
    Yasuda, Keiko
    Takeuchi, Yusuke
    Hirota, Keiji
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (03) : 283 - 297
  • [8] Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection
    Simmons, Jason D.
    Stein, Catherine M.
    Seshadri, Chetan
    Campo, Monica
    Alter, Galit
    Fortune, Sarah
    Schurr, Erwin
    Wallis, Robert S.
    Churchyard, Gavin
    Mayanja-Kizza, Harriet
    Boom, W. Henry
    Hawn, Thomas R.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2018, 18 (09) : 575 - 589
  • [9] Study of IL-6 and vitamin D3 in patients of pulmonary tuberculosis.[J].Shubhangi M. Dalvi;Nagsen N. Ramraje;Vinayak W. Patil;Rohit Hegde;Neelam Yeram.Indian Journal of Tuberculosis.2019, 3
  • [10] Interleukin-6: a potential biomarker of the success of tuberculosis treatment.[J].P.P. Singh.International Journal of Infectious Diseases.2016,